Article Text

Download PDFPDF
Candia albicans lumbar spondylodiscitis contiguous to infected abdominal aortic aneurysm in an intravenous drug user
  1. Tsuyoshi Yamada1,2,
  2. Shigeo Shindo1,
  3. Kazuyuki Otani1 and
  4. Osamu Nakai1
  1. 1Department of Orthopaedic Surgery, Kudanzaka Hospital, Tokyo, Japan
  2. 2Department of Orthopaedic Surgery, Tokyo Medical and Dental University, Tokyo, Japan
  1. Correspondence to Dr Tsuyoshi Yamada; yamada.orth{at}tmd.ac.jp

Abstract

While the incidence of spondylodiscitis is rising because of longer life expectancy and the increasing use of immunosuppressant drug, indwelling devices and spinal surgeries, the fungal aetiology remains rare, sometimes affecting intravenous drug users. Candida spondylodiscitis is an extremely rare complication post aortic aneurysm repair. It is potentially fatal due to the risk of aneurysm rupture and septic complications. The growing problem of systemic diseases caused by Candida species reflects the enormous increase of patients at risk. The treatment of this complicated entity is challenging and often requiring a multidisciplinary team. We reported the rare case of Candida spondylodiscitis contiguous to infected aortic aneurysm in a 74-year-old male intravenous drug user, to the extent which the vertebral body bony destruction progressed to need one-stage posterior and anterior spinal fusion surgery with curettage. Our surgical intervention combined with prolonged course of antifungal therapy could successfully eradicate the infection and resolve the neurological deficits.

  • orthopaedics
  • neurosurgery
  • bone and joint infections

Statistics from Altmetric.com

Footnotes

  • Contributors TY, SS, KO and ON were involved in patient management. TY and ON prepared the manuscript. All authors have revised the manuscript and approved of the final draft.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.